의료 방사선 차폐 시장은 CAGR 5.14%로 2025년 13억 4,000만 달러에서 2030년에는 17억 2,100만 달러로 성장할 것으로 예측됩니다.
만성 질환의 유병률 상승
만성 질환, 특히 암의 발생률 증가가 의료 방사선 차폐 시장의 주요 성장 요인입니다. X선, CT 스캔, 방사선 치료와 같은 시술은 환자와 의료진을 유해한 전리 방사선으로부터 보호하기 위해 강력한 차폐가 필요하기 때문에 차폐 재료 및 솔루션에 대한 수요가 촉진되고 있습니다.
영상 진단 및 방사선 치료 성장
진단 영상 센터 및 방사선 치료 시설의 확장은 시장 성장을 촉진하고 있습니다. 조기 질환 발견과 예방 의료에 대한 강조로 인해 영상 검사 건수가 증가했으며, 미국 핵의학학회(Society of Nuclear Medicine)에 따르면 연간 약 2천만 건의 핵의학 검사가 수행되고 있습니다. X선, CT, MRI, 방사선 치료 등 진단 및 치료 응용 분야의 급증은 병원, 진단 센터, 치과 및 수의과 클리닉 등 전문 시설에서 안전을 보장하기 위해 고급 방호 솔루션이 필수적입니다.
의료 종사자의 건강 위험
만성 저선량 방사선 노출은 의료진에게 뇌, 피부, 갑상선, 유방 암, 흑색종, 백내장, 뇌졸중, 동맥경화증, 인지 장애 등 심각한 건강 위험을 초래합니다. 전통적인 납 가운은 효과적이지만 부피가 크고 물리적 부담을 초래하며, 특히 의사들에게 허리 통증을 유발합니다. 머리나 눈과 같은 차폐되지 않은 부위는 뇌종양과 백내장의 위험을 높입니다. 이러한 우려로 인해 직업 안전을 강화하기 위한 경량적이고 효과적인 차폐 솔루션의 혁신이 촉진되고 있습니다.
기술 혁신
시장 업체들은 혁신적인 차폐 솔루션을 통해 안전 문제를 해결하고 있습니다. 2023년에 SDS Specialist Door Solutions는 의료 시설에서 방사선 시설에 맞춤형 방사선 보호를 제공하기 위해 설계된 Shieldoor 납 코팅 X-ray 도어를 출시했습니다. 2023년 4월, Mirion Technologies는 PTW Dosimetry를 인수해 방사선 보호 및 모니터링 시스템 포트폴리오를 강화했습니다. Radiaction Medical Ltd.는 2023년 4월 Shield System에 대해 FDA 510(k) 승인을 획득했으며, 이 혁신적인 방사선 보호 솔루션을 미국에서 출시하고 유럽으로 확장하기 위해 USD 10백만 달러를 확보했습니다. 인도에서는 고급 재료 및 공정 연구소(CSIR-AMPRI)가 원자력 규제 위원회(AERB)의 승인을 받은 납 없는 방사선 차폐 타일을 개발했으며, 2024년까지 마하라슈트라 주 사이디프 병원의 X선실, CT 스캔실, 카테터실 등에 2,600개의 타일이 설치될 예정입니다. 또한, 2023년 8월 MXR Imaging Inc.는 Spartan Shielding을 인수하여 MRI 실용 RF, 자기 및 방사선 보호 기능을 강화했습니다. 텅스텐 및 비스무트 합금과 같은 무연 재료의 개발을 포함한 이러한 발전은 더 안전하고 가벼우며 환경 친화적인 차폐 솔루션으로의 전환을 반영합니다.
The Medical Radiation Shielding Market is expected to grow from USD 1.340 billion in 2025 to USD 1.721 billion in 2030, at a CAGR of 5.14%.
Rising Prevalence of Chronic Diseases
The increasing incidence of chronic diseases, particularly cancer, is a primary driver of the medical radiation shielding market. In 2024, an estimated 2,001,140 new cancer cases were diagnosed in the United States alone, with 611,720 deaths, according to the National Institutes of Health. Globally, cancer remains a leading cause of mortality, necessitating advanced diagnostic imaging and radiation therapy. Procedures such as X-rays, CT scans, and radiation therapy require robust shielding to protect patients and healthcare workers from harmful ionizing radiation, driving demand for shielding materials and solutions.
Growing Diagnostic Imaging and Radiation Therapy
The expansion of diagnostic imaging centers and radiation therapy facilities is fueling market growth. The emphasis on early disease detection and preventive healthcare has increased the number of imaging procedures, including nearly 20 million nuclear medicine procedures performed annually in the U.S., as reported by the Society of Nuclear Medicine. This surge in diagnostic and therapeutic applications, including X-ray, CT, MRI, and radiation therapy, necessitates advanced shielding solutions to ensure safety in hospitals, diagnostic centers, and specialized facilities like dental and veterinary clinics.
Health Risks to Medical Professionals
Chronic low-dose radiation exposure poses significant health risks to medical staff, including increased incidences of brain, skin, thyroid, and breast cancers, melanomas, cataracts, strokes, atherosclerotic disease, and cognitive impairments. Traditional lead gowns, while effective, are bulky and cause physical strain, particularly back pain, among physicians. Unshielded areas, such as the head and eyes, heighten risks of brain tumors and cataracts. These concerns are driving innovation in lightweight, effective shielding solutions to enhance occupational safety.
Technological Innovations
Market players are addressing safety challenges through innovative shielding solutions. In 2023, SDS Specialist Door Solutions launched Shieldoor lead-lined X-ray doors, designed for healthcare settings to provide customizable radiation protection in radiology facilities. In April 2023, Mirion Technologies acquired PTW Dosimetry, enhancing its portfolio of radiation shielding and monitoring systems. Radiaction Medical Ltd. received FDA 510(k) clearance in April 2023 for its Shield System, securing USD 10 million to launch this innovative radiation protection solution in the U.S. and expand in Europe. In India, the Advanced Materials and Processes Research Institute (CSIR-AMPRI) developed lead-free radiation shielding tiles, approved by the Atomic Energy Regulatory Board, with 2,600 tiles installed at Saideep Hospital in Maharashtra for X-ray rooms, CT scan rooms, and cath labs by 2024. Additionally, in August 2023, MXR Imaging Inc. acquired Spartan Shielding, bolstering its capabilities in RF, magnetic, and radiation protection for MRI rooms. These advancements, including lead-free materials like tungsten and bismuth alloys, reflect a shift toward safer, lighter, and environmentally friendly shielding solutions.
Market Segmentation
The market is segmented by product type, solution, and end-user. In 2023, the shields segment held a 41.7% market share due to its customizable protection for radiation therapy, as reported by Coherent Market Insights. X-ray shielding dominated in 2023, accounting for 45% of revenue, driven by widespread use in medical imaging, while MRI shielding is the fastest-growing segment due to increasing demand for advanced MRI technologies. Diagnostic shielding led the solution segment in 2023, but radiation therapy shielding is expected to grow rapidly, fueled by rising cancer treatments. Hospitals and diagnostic centers held the largest end-user share in 2023, with research institutes poised for significant growth.
Regional Insights
North America accounted for 37.09% of the market in 2023, driven by advanced healthcare infrastructure, high cancer prevalence, and stringent safety regulations. The U.S. performed over 80 million CT scans in 2023, necessitating robust shielding solutions. Asia-Pacific is the fastest-growing region, propelled by healthcare infrastructure investments in countries like China and India, where cancer incidence is projected to rise by 12.8% by 2025, according to the NIH.
Market Challenges
High costs of advanced shielding materials and R&D, coupled with a shortage of skilled radiologists and oncologists, pose challenges. Regulatory compliance and the environmental concerns of lead-based shielding also necessitate ongoing innovation in non-toxic alternatives.
Conclusion
The medical radiation shielding market is set to grow from USD 1.51 billion in 2024 to USD 2.5 billion by 2032, at a CAGR of 6.52%, driven by rising chronic disease prevalence, diagnostic imaging growth, and occupational safety concerns. Innovations in lead-free and lightweight shielding solutions, alongside regional healthcare investments, are key growth catalysts. However, high costs and regulatory challenges require strategic advancements to sustain market momentum.
What do businesses use our reports for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence
Segmentation